男女羞羞视频在线观看,国产精品黄色免费,麻豆91在线视频,美女被羞羞免费软件下载,国产的一级片,亚洲熟色妇,天天操夜夜摸,一区二区三区在线电影
Chinadaily.com.cn
 
Go Adv Search

China's mums key to Nestle baby milk deal

Updated: 2012-04-25 11:19

(Agencies)

  Comments() Print Mail Large Medium  Small

LONDON/BEIJING - The rise of the middle-class Chinese working mothers helps explain why Nestle paid nearly $12 billion for Pfizer's baby food business and could leave rivals scrambling to catch up.

Across emerging markets, nowhere more than in China, women are increasingly keeping jobs after having children -- a big driving force behind 10 percent annual growth in the $30 billion a year baby food industry.

Foreign labels such as SMA, Promil and S-26 Gold, which Nestle will get with the Pfizer deal, have a definite edge. Nestle's products include Nan, Gerber, Lactogen and Nestogen, but are less well known in China.

Baby milk was the foundation of the world's biggest food company, established in 1866 when German pharmacist Henri Nestle introduced a substitute for mothers who could not breast-feed.

Paying more for the Pfizer unit than the $10 billion that analysts had expected, Nestle trumped a bid from Danone and Mead Johnson.

The Pfizer nutrition business has 85 percent of its sales in emerging markets, and a quarter of sales in China.

Fuelled by 16 million new births a year, annual growth rates for China's baby formula market have been as high as 20 percent over the last five years. The market is forecast to double to $16 billion by 2016.

"The key strategic attraction of the deal in our view is Pfizer's No 5 position in the Chinese infant formula market where despite being global No 1 player in infant formula, Nestle has a relatively weak presence," said analyst Robert Dickinson at brokers Citi.

The Swiss giant is already market leader in milk formula in Latin America, Africa and the Middle East. This brings it the No 1 spot in Asia with its presence outside China counted too.

Globally, Nestle's baby food market share will rise to 25 percent from 19 percent - although this is likely to fall slightly after sell-offs to ensure regulatory clearance. Mead has 16 percent, Danone 14 percent and Abbott Laboratories 12 percent.

Few options for competitors

The Nestle-Pfizer business in China would only have a combined 12 percent market share behind Mead's leading 16 percent and Danone on 14 percent, but that would still be a rise from 10th place and there may be room for expansion.

Analysts looking at China expect the number of middle class households to double to 100 million by 2015.

主站蜘蛛池模板: 简阳市| 云南省| 屏东县| 延边| 龙口市| 江安县| 睢宁县| 浏阳市| 金溪县| 加查县| 太湖县| 佛坪县| 桑植县| 博客| 巴彦淖尔市| 固阳县| 凤翔县| 稷山县| 青龙| 尉氏县| 隆化县| 高雄市| 望江县| 施秉县| 潼南县| 正蓝旗| 伊宁市| 阳原县| 上杭县| 林州市| 盘山县| 鞍山市| 彩票| 景宁| 成武县| 万源市| 巴马| 慈利县| 清涧县| 楚雄市| 双江| 宁陵县| 德保县| 时尚| 星座| 甘谷县| 洪洞县| 枣庄市| 浑源县| 息烽县| 汝城县| 柯坪县| 永城市| 胶州市| 稻城县| 大方县| 梨树县| 临湘市| 顺平县| 炎陵县| 门头沟区| 会同县| 庆云县| 稻城县| 改则县| 江川县| 凤冈县| 江川县| 宜昌市| 贡嘎县| 长兴县| 建始县| 大冶市| 满城县| 廊坊市| 虞城县| 潮州市| 兴山县| 韶关市| 新化县| 马山县| 繁昌县|